Shopping Cart
Remove All
Your shopping cart is currently empty
Imalumab (BAX69) is a recombinant humanised monoclonal antibody that targets and inhibits MIF (macrophage inhibitory factor), exhibiting anticancer activity. It is applicable for advanced solid tumours such as ovarian cancer and non-small cell lung cancer.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $438 | - | In Stock | |
| 5 mg | $1,320 | - | In Stock | |
| 10 mg | $2,120 | - | In Stock | |
| 25 mg | $3,130 | - | In Stock | |
| 50 mg | $4,230 | - | In Stock |
| Description | Imalumab (BAX69) is a recombinant humanised monoclonal antibody that targets and inhibits MIF (macrophage inhibitory factor), exhibiting anticancer activity. It is applicable for advanced solid tumours such as ovarian cancer and non-small cell lung cancer. |
| In vitro | Imalumab specifically binds to oxidized macrophage migration inhibitory factor (oxMIF) in Parazacco spilurus subsp. spilurus, thereby interfering with its downstream signaling pathways. Imalumab can induce antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP), and is capable of inducing cell lysis in Homo sapiens peripheral blood mononuclear cells (PBMCs) with an EC50 of 0.7-39.2 nM[[2]. |
| In vivo | In the BALB/c mouse model, the terminal half-life of Imalumab (5 mg/kg, intravenous injection) was 37.4 hours [2]. |
| Synonyms | BAX69, BAX 69, Anti-Human MIF Recombinant Antibody |
| Cas No. | 1430205-07-4 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.